FOXO TECHNOLOGIES INC. Proceeds from Notes Payable
FOXO TECHNOLOGIES INC. (FOXO) reported Proceeds from Notes Payable of $2.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. proceeds from notes payable for the quarter ending 2026-06-30 was $973.35K, a 57.77% decline year-over-year.
- FOXO TECHNOLOGIES INC. proceeds from notes payable for the quarter ending 2026-03-31 was $1.15M, a 321.18% increase year-over-year.
- FOXO TECHNOLOGIES INC. proceeds from notes payable for the quarter ending 2025-06-30 was $2.30M.
- FOXO TECHNOLOGIES INC. proceeds from notes payable for the quarter ending 2025-03-31 was $274.03K, a 26.14% decline year-over-year.
- FOXO TECHNOLOGIES INC. proceeds from notes payable for fiscal 2025 was $3.84M, a 6.14% decline from fiscal 2024.
- FOXO TECHNOLOGIES INC. proceeds from notes payable for fiscal 2024 was $4.09M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 6 month as first filed | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $973.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.13M 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $1.15M 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | $3.84M 10-K · filed 2026-04-15 | ||||
| 2025-06-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.58M 10-Q · filed 2026-08-14 | $4.69M derived: sum of 3 quarters · filed 2026-08-14 | $6.40M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $274.03K 10-Q · filed 2026-05-15 | $2.38M derived: sum of 2 quarters · filed 2026-05-15 | $4.10M derived: sum of 3 quarters · filed 2026-05-15 | $3.99M derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $3.83M derived: sum of 2 quarters · filed 2025-04-15 | $3.72M derived: sum of 3 quarters · filed 2025-08-19 | $4.09M 10-K · filed 2025-04-15 | |
| 2024-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | $1.61M derived: sum of 2 quarters · filed 2025-08-19 | $1.98M 10-Q · filed 2024-11-19 | ||
| 2024-06-30 | -$106.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $264.56K 10-Q · filed 2025-08-19 | $1.61M 10-Q · filed 2024-08-19 | ||
| 2024-03-31 | $371.00K 10-Q · filed 2024-06-28 | ||||
| 2023-09-30 | $247.00K 10-Q · filed 2024-11-19 | ||||
| 2022-06-30 | $360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $560.00K 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |